This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International: COVID-19 Therapeutic Development & Production
April 27-28, 2025
Delivered in a 100% Virtual FormatEastern Daylight Time (EST)

Dan Spacie
Chief Executive Officer at BioPhorum
Speaker

Profile

Dan Spacie has more than 30 years’ leadership experience.

He has worked across several industries including biopharmaceuticals, banking and consulting.

He entered the healthcare/pharmaceutical sector 15 years ago to lead the acquisition and integration of an SME pharmaceutical company into STADA, where he then relaunched the assets into Europe and US alongside the introduction of a novel infusion medical device. He continued his work in the pharmaceutical market developing assets and taking them through to commercialization across multiple geographies.

Specializing in strategic planning and execution, Dan enjoys collaborating with teams and stakeholders, and building sustainable growth.

Agenda Sessions

  • How the collaboration model is accelerating the Biopharmaceutical Industry

    13:05